Concepedia

Astrid Mayer

AM

6

Publications

788

Citations

6

H-Index

1993

Active since

Affiliations

University College London(Current)

Royal Free London NHS Foundation Trust

Wilhelminen Hospital

Astrid Mayer is an author at University College London specializing in antibody engineering, medicine, and oncology.

Top concepts

Publications per year

1993–2020

6

Publications

6

The prognostic significance of proliferating cell nuclear antigen, epidermal growth factor receptor, andmdr gene expression in colorectal cancer

Astrid Mayer, Masafumi Takimoto, E. Fritz et al. · Cancer · 1993 · 412 citations · Full text

Systemic chemotherapy with or without cetuximab in patients with resectable colorectal liver metastasis (New EPOC): long-term results of a multicentre, randomised, controlled, phase 3 trial

John Bridgewater, S. Pugh, Tom Maishman et al. · The Lancet Oncology · 2020 · 227 citations · Full text

A Phase I Study of Single Administration of Antibody-Directed Enzyme Prodrug Therapy with the Recombinant Anti–Carcinoembryonic Antigen Antibody-Enzyme Fusion Protein MFECP1 and a Bis-Iodo Phenol Mustard Prodrug

Astrid Mayer, Roslyn J. Francis, Surinder K. Sharma et al. · Clinical Cancer Research · 2006 · 80 citations

, , +19

Ki-67 index and response to chemotherapy in patients with neuroendocrine tumours

Alexa Childs, Amy A. Kirkwood, Julien Edeline et al. · Endocrine Related Cancer · 2016 · 26 citations · Full text

Immunohistochemical Evaluation of Cathepsin D Expression in Colorectal Cancer

Astrid Mayer, E. Fritz, René H. Fortelny et al. · Cancer Investigation · 1997 · 24 citations

Rows per page

1–5 of 6